Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008

30.07.08 - 21:44 ... source : Endocare

... Publication Highlights the Treatment's 'Low Rates of Morbidity' IRVINE, Calif., July 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation, announced today that focal cryoablation was highlighted as having "low morbidity" in the July issue of Urology Times. Focal cryoablation is a minimally-invasive method of freezing and destroying only the cancerous portion of the prostate gland while leaving the healthy tissue and the nerves intact, resulting in low overall morbidity and a high rate of sexual potency. Focal cryoablation represents an important new option for prostate cancer patients who have isolated, localized disease. Noting the data presented at the annual meeting of the Am ...» Next (HTML)